An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

PHASE3CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 29, 2008

Conditions
HyperlipidemiaMixed Dyslipidemia
Interventions
DRUG

Niacin ER/Simvastatin Tablets

Up to 2000 mg/40 mg at bedtime

DRUG

atorvastatin

40 mg at bedtime

Trial Locations (46)

15206

Pittsburgh

16025

Chicora

16635

Duncansville

19438

Harleysville

21204

Baltimore

23249

Richmond

27262

High Point

28204

Charlotte

30034

Decatur

30338

Dunwoody

30701

Calhoun

32117

Daytona Beach

32605

Gainesville

32953

Merritt Island

33026

Pembroke Pines

33126

Miami

33770

Largo

34613

Brooksville

44406

Canfield

45242

Cincinnati

45458

Dayton

53051

Menomonee Falls

53209

Milwaukee

55508

Topeka

59808

Missoula

60607

Chicago

66216

Shawnee Mission

67005

Arkansas City

67114

Newton

67203

Wichita

75006

Carrollton

75251

Dallas

77074

Houston

78224

San Antonio

78752

Austin

83704

Boise

84044

Magna

84107

Salt Lake City

90255

Huntington Park

90822

Long Beach

92801

Anaheim

94598

Walnut Creek

95825

Sacramento

97239

Protland

98335

Gig Harbor

04210

Auburn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY